Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in immunotherapy for MMR proficient colorectal cancer.
Lote H, Starling N, Pihlak R, Gerlinger M. Lote H, et al. Among authors: starling n. Cancer Treat Rev. 2022 Dec;111:102480. doi: 10.1016/j.ctrv.2022.102480. Epub 2022 Nov 1. Cancer Treat Rev. 2022. PMID: 36335756 Free article. Review.
The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY, Cunningham D, Barber LJ, Campbell J, Chen L, Kozarewa I, Fenwick K, Assiotis I, Guettler S, Garcia-Murillas I, Awan S, Lambros M, Starling N, Wotherspoon A, Stamp G, Gonzalez-de-Castro D, Benson M, Chau I, Hulkki S, Nohadani M, Eltahir Z, Lemnrau A, Orr N, Rao S, Lord CJ, Ashworth A. Chong IY, et al. Among authors: starling n. J Pathol. 2013 Nov;231(3):301-10. doi: 10.1002/path.4247. J Pathol. 2013. PMID: 24308032
Role of erlotinib in the management of pancreatic cancer.
Starling N, Neoptolemos J, Cunningham D. Starling N, et al. Ther Clin Risk Manag. 2006 Dec;2(4):435-45. doi: 10.2147/tcrm.2006.2.4.435. Ther Clin Risk Manag. 2006. PMID: 18360654 Free PMC article.
Colorectal cancer.
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Cunningham D, et al. Among authors: starling n. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. Lancet. 2010. PMID: 20304247 Review.
Current and Future Therapies for Advanced Gastric Cancer.
Davidson M, Okines AF, Starling N. Davidson M, et al. Among authors: starling n. Clin Colorectal Cancer. 2015 Dec;14(4):239-50. doi: 10.1016/j.clcc.2015.05.013. Epub 2015 Jun 6. Clin Colorectal Cancer. 2015. PMID: 26524924 Review.
Targeting deficient DNA damage repair in gastric cancer.
Young K, Starling N, Cunningham D. Young K, et al. Among authors: starling n. Expert Opin Pharmacother. 2016 Sep;17(13):1757-66. doi: 10.1080/14656566.2016.1217992. Epub 2016 Aug 8. Expert Opin Pharmacother. 2016. PMID: 27488684 Review.
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
Khan K, Rata M, Cunningham D, Koh DM, Tunariu N, Hahne JC, Vlachogiannis G, Hedayat S, Marchetti S, Lampis A, Damavandi MD, Lote H, Rana I, Williams A, Eccles SA, Fontana E, Collins D, Eltahir Z, Rao S, Watkins D, Starling N, Thomas J, Kalaitzaki E, Fotiadis N, Begum R, Bali M, Rugge M, Temple E, Fassan M, Chau I, Braconi C, Valeri N. Khan K, et al. Among authors: starling n. Gut. 2018 Aug;67(8):1484-1492. doi: 10.1136/gutjnl-2017-314178. Epub 2017 Aug 8. Gut. 2018. PMID: 28790159 Free PMC article. Clinical Trial.
132 results